• Subscribe
  • About us
  • Advertise with us

NeuroSens

Menu

Skip to content
  • Home
  • Neurology
  • Psychiatry

Long-acting injectable aripiprazole approved in Canada

August 13, 2014
Recommend to a Colleague print
 

Aripiprazole data summary: efficacy and safety results
Underutilization of LAIs
Commentary by Dr. Ofer Agid, Centre for Addiction and Mental Health, Associate Professor of Psychiatry, University of Toronto, Toronto, Canada.

A once-monthly long-acting injectable (LAI) formulation of aripiprazole (Abilify Maintena; Otsuka Pharmaceuticals Canada Inc.) has now been approved by Health Canada for maintenance treatment of adult patients with schizophrenia.

It takes 30 seconds
or login using your email address

Please enter the email address that you registered the newsletter with

TOPICS: PSYCHIATRY, SCHIZOPHRENIA
Recommend to a Colleague

Related Posts

  • Improving QoL in patients with schizophrenia
    December 5, 2018
  • Canadian real-world study of aripiprazole LAI in schizophrenia
    August 23, 2018
  • Use of injectable antipsychotics in bipolar I disorder
    June 29, 2018
  • Sun avoidance – more harm than good?
    December 16, 2016
  • APA highlights: Treatment trials in psychiatry
    June 22, 2016
Go back to home page

Browse by Topic

MS (309)
AD (81)
PD (77)
COVID-19 (45)
PREVIOUS CONGRESSES (37)
DEPRESSION (36)
MIGRAINE (26)
SCHIZOPHRENIA (25)
STROKE (22)
EPILEPSY (21)
ECTRIMS 2015 (13)
AAN 2015 (11)
ECTRIMS 2021 (10)
ECTRIMS 2019 (10)
ECTRIMS 2014 (10)
DEMENTIA (10)
AAN 2013 (9)
ECTRIMS 2013 (9)
AAN 2014 (9)
ECTRIMS 2018 (9)
MS SEQUENCING (9)
PSYCHIATRY (8)
ACTRIMS-ECTRIMS 2020 (7)
AAN 2019 (7)
AAN 2021 (6)
ECTRIMS 2017 (6)
CHARCOT 2013 (6)
BIPOLAR (5)
AAN 2022 (5)
CCSVI (5)
ANXIETY (5)
Library (5)
ECTRIMS 2016 (5)
NeuroSound (4)
EAN 2015 (4)
BPD (4)
AAN 2017 (3)
PAIN (3)
ENS 2013 (3)
AAN 2020 (3)
AAN 2018 (2)
NEW DRUGS (2)
EAN 2020 (2)
APA 2014 (2)
SLEEP (2)
SPECIAL REPORT (2)
ADDICTION (1)
ACTRIMS 2022 (1)
EAN 2019 (1)
EAN 2021 (1)
CONCUSSION (1)
CIDP (1)
LUMBAR PUNCTURE (1)
WEST NILE (1)
INSOMNIA (1)
TSC (1)
LGS (1)
ALS (1)
SEIZURE (1)
GUIDELINES (1)
AAN 2016 (1)
APA 2016 (1)
hATTR (1)
Dravet syndrome (1)
EAN 2016 (0)
CLINICAL CASES IN MS (0)
ECTRIMS 2020 (0)
View all Topics

Popular Posts

  • Evolving picture of cognitive dysfunction in MS posted on May 19, 2022
  • CLINICAL CASES IN MS – CASE 5: A CLINICALLY STABLE PATIENT PLANNING A PREGNANCY posted on May 5, 2022
  • 6 criteria to improve PMS outcomes posted on May 2, 2022
Copyright 2022 Lind Publishing Inc All rights reserved. Developed by Integration New Media, INC. (INM)
Contact Us Terms and Conditions